Grifols GIFLF
NASDAQ GIFLF
$11.08 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Grifols (GIFLF) Dividends Paid - Common (2013 - 2025)

Grifols' (GIFLF) quarterly Dividends Paid - Common came in at -$149.0 million in Q4 2025, down 13843.31% on a YoY basis from N/an in Q4 2024, and down 13843.31% quarter-over-quarter from -$1.1 million in Q4 2024.

Analysis

Grifols (GIFLF) Dividends Paid - Common (2013 - 2025) Analysis & Trends

Grifols (GIFLF) has reported Dividends Paid - Common for 10 consecutive years, with -$149.0 million the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Dividends Paid - Common fell 13843.31% year-over-year to -$149.0 million; the trailing twelve-month figure through Dec 2025 stood at -$248.7 million (down 521.39% YoY), and the FY2025 full-year result was -$144.6 million, down 13433.26% from the prior year.
  • Dividends Paid - Common eased to -$149.0 million in Q4 2025 per GIFLF's latest filing, from -$1.1 million in the prior quarter.
  • Across five years, Dividends Paid - Common topped out at $10.3 million in Q4 2022 and bottomed at -$149.0 million in Q4 2025.
  • Historically, Dividends Paid - Common has averaged -$46.6 million across 3 years, with a median of -$1.1 million in 2024.
  • The widest YoY moves for Dividends Paid - Common: up 13843.31% in 2025, down 13843.31% in 2025.
  • Over 3 years, Dividends Paid - Common stood at $10.3 million in 2022, then slumped by 110.34% to -$1.1 million in 2024, then slumped by 13843.31% to -$149.0 million in 2025.
  • According to Business Quant data, Dividends Paid - Common over the past three periods registered -$149.0 million, -$1.1 million, and $10.3 million for Q4 2025, Q4 2024, and Q4 2022 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends Paid - Common (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn 1.36 Bn
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn 1.03 Bn
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn 96.80 Mn
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn -
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn -
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn -
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn -
10 Grifols 7.54 Bn 9.09 Bn 3.33 Bn -149.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -149.00 Mn
Dec 31, 2024 -1.07 Mn
Dec 31, 2022 10.33 Mn
Dec 31, 2019 -108.94 Mn
Dec 31, 2018 158.70 Mn
Dec 31, 2017 112.18 Mn
Dec 31, 2016 -132.71 Mn
Sep 30, 2016 -208.15 Mn
Dec 31, 2015 -355.06 Mn
Dec 31, 2014 107.42 Mn
Dec 31, 2013 -1,361.09
Sep 30, 2013 1,325.04